Your browser doesn't support javascript.
loading
Utility of oral fluid samples for hepatitis B antibody detection in real life conditions.
Cruz, Helena Medina; de Paula, Vanessa Salete; da Silva, Elisangela Ferreira; do Ó, Kycia Maria Rodrigues; Milagres, Flavio Augusto Pádua; Cruz, Marcelo Santos; Bastos, Francisco Inácio; da Mota, Jurema Corrêa; Pollo-Flores, Priscila; Leal, Erotildes; Motta-Castro, Ana Rita Coimbra; Lewis-Ximenez, Lia Laura; Lampe, Elisabeth; Villar, Livia Melo.
Afiliação
  • Cruz HM; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
  • de Paula VS; Molecular Virology Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
  • da Silva EF; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
  • do Ó KMR; São Lucas Hospital, Petropolis, Rio de Janeiro, Brazil.
  • Milagres FAP; Medicine Faculty, Federal University of Tocantins, Palmas, Brazil.
  • Cruz MS; Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Bastos FI; Institute of Communication and Scientific Information & Technology for Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • da Mota JC; Institute of Communication and Scientific Information & Technology for Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Pollo-Flores P; Antonio Pedro University Hospital, Federal Fluminense University, Rio de Janeiro, Brazil.
  • Leal E; Federal University of Rio de Janeiro, Faculty of Medicine, Rio de Janeiro, Brazil.
  • Motta-Castro ARC; Federal University of Mato Grosso do Sul and FIOCRUZ-MS, Campo Grande, MS, Brazil.
  • Lewis-Ximenez LL; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
  • Lampe E; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
  • Villar LM; Laboratory of Viral Hepatitis, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil. liviafiocruz@gmail.com.
BMC Infect Dis ; 19(1): 632, 2019 Jul 17.
Article em En | MEDLINE | ID: mdl-31315573
ABSTRACT

BACKGROUND:

Hepatitis B virus (HBV) testing in oral fluid samples may provide advantages in diagnosis, screening or prevalence studies, especially among individuals with venous access difficulties. This study aims to optimize one commercially available assay for detecting total anti-HBc marker in oral fluid samples and to evaluate its utility under real life conditions in different settings for the purposes of prevalence and diagnostic studies.

METHODS:

Oral fluid was collected using a Salivette device and some parameters were initially evaluated type of elution buffer and sample volume. Thereafter, the utility of oral fluid samples for detection of anti-HBc was evaluated in real life conditions in which, 1296 individuals gave serum and oral fluid samples. All serum samples were submitted to commercial EIAs to detect total anti-HBc, according to the manufacturer's instructions and oral fluid samples according to previous optimization.

RESULTS:

In optimization evaluation, PBS/BSA 0.5% and 100 µL of oral fluid (volume was two-fold increased compared to serum in EIA) were chosen as transport buffer and sample volume. In the field study, anti-HBc was detected in 211 out of 1296 serum samples giving overall oral fluid sensitivity of 52.6% and specificity of 96%. Concordance was higher in ambulatory setting (67.7) compared to general population (31.8). Mean ± standard deviation values of optical density/cutoff (OD/CO) in serum samples were higher in false-negative oral fluid samples than those seen in true positive samples. Sensitivity was higher in those presenting active infection compared to anti-HBc isolate and past infection. Sensitivity also increased in the ambulatory group when HCV individuals were excluded.

CONCLUSIONS:

It was possible to optimize a commercial EIA for detecting anti-HBc in oral fluid samples and where the highest concordance was found in ambulatory settings and among individuals with active infection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saliva / Técnicas Imunoenzimáticas / Hepatite B / Anticorpos Anti-Hepatite B Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Saliva / Técnicas Imunoenzimáticas / Hepatite B / Anticorpos Anti-Hepatite B Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article